Skip to content

Mindfulness-Action Based Cognitive Behavioral Therapy for concurrent Binge Eating Disorder and Substance Use Disorders.

Christine M Courbasson, Yasunori Nishikawa, Leah B Shapira

Eating Disorders 2011 DOI: 10.1080/10640266.2011.533603 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot study Peer reviewed
Sample size 38
Population Individuals diagnosed with binge eating disorder and comorbid substance use disorder
Intervention Mindfulness-Action Based Cognitive Behavioral Therapy (MACBT)
Duration 16-week intervention
Topics Addiction Meditation
Keywords Humans Substance-related disorders Treatment outcome Pilot projects Comorbidity Adult Middle aged Female Mind-body therapies Binge-eating disorder Cognitive behavioral therapy
Key points Participants with co-existing binge eating disorder and substance use disorder improved significantly after 16 weeks of group Mindfulness-Action Based Cognitive Behavioral Therapy on objective binge eating episodes, disordered eating attitudes, alcohol and drug addiction severity, and depression. The authors conclude the approach appears promising for this population.

Abstract

Individuals with Binge Eating Disorder (BED) often evidence comorbid Substance Use Disorders (SUD), resulting in poor outcome. This study is the first to examine treatment outcome for this concurrent disordered population. In this pilot study, 38 individuals diagnosed with BED and SUD participated in a 16-week group Mindfulness-Action Based Cognitive Behavioral Therapy (MACBT). Participants significantly improved on measures of objective binge eating episodes; disordered eating attitudes; alcohol and drug addiction severity; and depression. Taken together, MACBT appears to hold promise in treating individuals with co-existing BED-SUD.

Comparable studies

Other non-randomized and open-label trials on addiction, most cited first.

Study Year Design Participants
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Psychiatrically healthy nicotine-dependent smokers 2014 Open-label pilot study n = 15
Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction Smokers 2015 Open-label pilot study n = 15
Ketamine Psychedelic Therapy (KPT): A Review of the Results of Ten Years of Research Alcoholic patients 1997 Controlled clinical trial n = 211
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder. Patients with alcohol use disorder (AUD) following community alcohol detoxification 2021 Open-label safety and tolerability proof-of-concept study n = 14
The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions Participants in a psilocybin-assisted treatment study for alcohol dependence 2018 Open-label pilot (proof-of-concept) study with qualitative content analysis n = 17

Citations in the library

Cited by 7

and 2 more in the library

Cites 9

and 4 more in the library

Explore topics